Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Sitowie | 2025 | Seed | $3.1M | Paris |
| Brink Therapeutics | 2025 | Seed | $4.0M | Paris |
| MSInsight | 2025 | Seed | $1.7M | Paris |
| Gama | 2025 | Non Equity Assistance | Undisclosed | Ivry-sur-seine |
| Iktos | 2025 | Grant | $2.6M | Paris |
| Moon Surgical | 2025 | Undisclosed | Undisclosed | Paris |
| Hopia | 2025 | Seed | $3.6M | Paris |
| Leakmited | 2025 | Series A | $5.2M | Carrières-sur-seine |
| Biomemory | 2024 | Series A | $18.0M | Paris |
| Okomera | 2024 | Grant | $1.6M | Paris |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 76 | Sitowie | Seed | $3.1M | Paris, France |
| 77 | Brink Therapeutics | Seed | $4.0M | Paris, France |
| 78 | MSInsight | Seed | $1.7M | Paris, France |
| 79 | Gama | Non Equity Assistance | Undisclosed | Ivry-sur-seine, France |
| 80 | Iktos | Grant | $2.6M | Paris, France |
| 81 | Moon Surgical | Undisclosed | Undisclosed | Paris, France |
| 82 | Hopia | Seed | $3.6M | Paris, France |
| 83 | Leakmited | Series A | $5.2M | Carrières-sur-seine, France |
| 84 | Biomemory | Series A | $18.0M | Paris, France |
| 85 | Okomera | Grant | $1.6M | Paris, France |
Sitowie develops SaaS technology and tools to understand the degradation of buildings.
Brink Therapeutics is a Biotechnology Research firm conducting cell therapy research using reprogrammed recombinases.
MSInsight bioinformatics start-up that develops diagnostic and treatment response prediction solutions for MSI cancers.
Gama is a space exploration and interplanetary transportation company.
Iktos is a deep learning technology platform focused on new drug design and discovery.
Moon Surgical develops a new category of robotic surgery that enhances existing clinical practice with collaborative and adaptive robotics.
Optimized resource planning solution for healthcare institutions
Leakmited is a company locate water leaking pipes using AI and Satellite Images.
Biomemory leverages molecular engineering to build exabyte appliances for data centers
Okomera is a biotech start-up that accelerates access to improved, precision-based cancer therapies.
Generare is a biotech startup that discovers next-generation medicines and high-value molecules hiding in soil bacteria.
Syntetica is a nylon recycling startup which solves the pollution problem in the fashion industry
InSpek develops a biological and chemical monitoring systems using integrated photonics.
AI-powered 3D vision for robots, helping manufacturers scale flexible automation across factories worldwide.
Nopillo provides tools to automate and optimize the tax declaration and the return on investment.
Harnessing Satellites & AI we provide reliable Ocean Data to make the right decisions at sea.
Edonia offers plant-based protein food production with low processed & micro-algae based ingredients.
Welinq is a quantum computing solution interconnecting processors.
MORFO incorporates biological symbioses, drones, and AI technologies to sustainably reforest and fight against global warming.
Quantiq is an AI video-based health monitoring solution that transforms any webcam or smartphone into a medical device.
Veeton is the creator of an artificial intelligence-powered platform for automated fashion imaging.
Re-imaging biomedical research
Predictive Solutions for Computer Aided Appearance Design CA²D.
Embodme is disrupting the interactive display industry by merging sensing and smart screen with a proprietary infrared pixel technology.
Metyos is a biosensor that can monitor the effects of your daily activities.
AGORANOV has invested in 159 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
AGORANOV's top investment sectors include Artificial Intelligence (AI), Biotechnology, Health Care, Medical Device, Information Technology. The firm invests across 52 different industry categories.
Among tracked funding rounds, Biomemory received $18.0M in a Series A round. AGORANOV's total known invested capital is $367.7M.
AGORANOV's average investment size is $4.5M across its portfolio of 159 companies.
Recent AGORANOV portfolio additions include Sitowie, Brink Therapeutics, MSInsight, Gama, Iktos. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors